Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 10 min ago
PreprintAll rights reservedmedRxiv

CNM-Au8 Treatment Is Associated With Reduced Chronic Lesion Tissue Expansion in Relapsing-Remitting Multiple Sclerosis

  • S. Klistorner1
  • M. Hotchkin
  • B. Greenberg
  • A. Rynders
  • R. Glanzman
  • H. Beadnall
  • S. Vucic
  • R. MacDonell
  • J. Lechner-Scott
  • W. Carroll
  • S. Blum
  • A. Van der Walt
4 more authors
  • B. Taylor
  • D. Field
  • M. Barnett
  • A. Klistorner1
  1. 1Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia
Read full textPDFDOICite

Related

  1. DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis.
    Bertrand Bourre, Olivier Guerrier, Xavier Ayrignac +7
    Journal of neurologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Salivary Proteomics Reveals Disease- and Therapy-Associated Molecular Patterns in Relapsing-Remitting Multiple Sclerosis
    Giulia Guadalupi, Cristina Contini, Chiara Piras +13
    BiomoleculesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  3. Subjective Sleep Quality in Relation to Relapse Status in Relapsing-Remitting Multiple Sclerosis: A Propensity Score—Matched Nested Case—Control Analysis
    Dimitar Taskov, Sonya Ivanova, Izabel Antova +4
    Neurology internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Repeated TRPA1 Blockade Reduces Nociception and Neuroinflammation in a Relapsing–Remitting Mouse Model of Multiple Sclerosis
    Ana Clara Machado Luiz, Diulle Spat Peres, Sabrina Qader Kudsi +8
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0PhysiologyCrossref
  5. Disease-modifying therapies (DMTs) discontinuation in older relapsing-remitting multiple sclerosis (RRMS) patients with stable disease: Two-year randomized, controlled trial.
    Sajjad Daneshyar, Masoud Ghiasian, Salman Khazaei +2
    Caspian journal of internal medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{klistorner2026cnmau8,
  title = {{CNM-Au8 Treatment Is Associated With Reduced Chronic Lesion Tissue Expansion in Relapsing-Remitting Multiple Sclerosis}},
  author = {S. Klistorner and M. Hotchkin and B. Greenberg and A. Rynders and R. Glanzman and H. Beadnall and S. Vucic and R. MacDonell and J. Lechner-Scott and W. Carroll and S. Blum and A. Van der Walt and B. Taylor and D. Field and M. Barnett and A. Klistorner},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.23.26363841},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.23.26363841v1},
}
RIS
TY  - UNPB
TI  - CNM-Au8 Treatment Is Associated With Reduced Chronic Lesion Tissue Expansion in Relapsing-Remitting Multiple Sclerosis
AU  - S. Klistorner
AU  - M. Hotchkin
AU  - B. Greenberg
AU  - A. Rynders
AU  - R. Glanzman
AU  - H. Beadnall
AU  - S. Vucic
AU  - R. MacDonell
AU  - J. Lechner-Scott
AU  - W. Carroll
AU  - S. Blum
AU  - A. Van der Walt
AU  - B. Taylor
AU  - D. Field
AU  - M. Barnett
AU  - A. Klistorner
PY  - 2026
DA  - 2026/09/23
PB  - medRxiv
DO  - 10.64898/2026.09.23.26363841
UR  - https://www.medrxiv.org/content/10.64898/2026.09.23.26363841v1
ER  -